Back to Search
DAVID GANDARA, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1528042587IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
C037929(CA)
Education
OTHER
Class of 1973
Research & Publications (20)
Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics.
PMID 19470925·J Clin Oncol·2009
8-other
Adjuvant chemotherapy of stage I non-small cell lung cancer in North America.
PMID 17603308·J Thorac Oncol·2007
8-other
Epidermal growth factor receptor inhibitors plus chemotherapy in non-small-cell lung cancer: biologic rationale for combination strategies.
PMID 17382026·Clin Lung Cancer·2007
6-review
Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504).
PMID 17026812·Clin Lung Cancer·2006
3-trial
Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment.
PMID 17409997·J Thorac Oncol·2006
4-observational
Integration of novel therapeutics into combined modality therapy of locally advanced non-small cell lung cancer.
PMID 16000614·Clin Cancer Res·2005
6-review
Therapeutic strategies for combined-modality therapy of locally advanced non-small-cell lung cancer: rationale for consolidation docetaxel therapy.
PMID 16384543·Clin Lung Cancer·2005
6-review
Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition.
PMID 15217959·Clin Cancer Res·2004
6-review
Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504.
PMID 12743155·J Clin Oncol·2003
3-trial
Tirapazamine: prototype for a novel class of therapeutic agents targeting tumor hypoxia.
PMID 11894020·Semin Oncol·2002
6-review
Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non--small cell lung cancer: focus on docetaxel.
PMID 11441412·Semin Oncol·2001
6-review
Molecular-clinical correlative studies in non-small cell lung cancer: application of a three-tiered approach.
PMID 11740998·Lung Cancer·2001
6-review
Gemcitabine in combination with new platinum compounds: an update.
PMID 11301843·Oncology (Williston Park)·2001
6-review
Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trial.
PMID 10623703·J Clin Oncol·2000
3-trial
Gemcitabine/carboplatin combination regimens: importance of dose schedule.
PMID 10960942·Oncology (Williston Park)·2000
6-review
Evolution of combined modality therapy for stage III non-small-cell lung cancer.
PMID 10981289·Oncology (Williston Park)·2000
6-review
Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339).
PMID 19096312·J Thorac Oncol·2009
3-trial
Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma.
PMID 19096314·J Thorac Oncol·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4501 X ST
SACRAMENTO, CA 95817 - Phone
- (916) 734-3772
Quick Facts
- NPI
- 1528042587
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 53
- Publications
- 20
Are you this provider?
Claim Your Profile